Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non-Clear Cell Renal Cell Carcinoma
Gespeichert in:
Veröffentlicht in: | Clinical cancer research 2021-06, Vol.27 (12), p.3503-3503 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3503 |
---|---|
container_issue | 12 |
container_start_page | 3503 |
container_title | Clinical cancer research |
container_volume | 27 |
creator | Armstrong, Andrew J Nixon, Andrew B Carmack, Andrea Yang, Qian Eisen, Tim Stadler, Walter M Jones, Robert J Garcia, Jorge A Vaishampayan, Ulka N Picus, Joel Hawkins, Robert E Hainsworth, John D Kollmannsberger, Christian K Logan, Theodore F Puzanov, Igor Pickering, Lisa M Ryan, Christopher W Protheroe, Andrew George, Daniel J Halabi, Susan |
description | |
doi_str_mv | 10.1158/1078-0432.CCR-21-1636 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2540516304</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2540516304</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2016-a31a72affe228dc0f67dd63d19587e6ad065402f460f8a39861840fa4f89fdd23</originalsourceid><addsrcrecordid>eNo9kc1u1TAQhS1ERcuFRwB5ySbFYydOLrurqPxIVYvasram8RgMiV1sp6jvwEPjq9uymiPNnJnRdxh7A-IUoBveg-iHRrRKno7jVSOhAa30M3YCXdc3SuruedVPM8fsZc4_hYAWRPuCHasWoBdye8L-jjElmoqP4QPfhe8-_vKBMt_lHCePhSz_48sPfrmWKS61ga5Q4tdr8MUHf8tj4mf3lOLslzXzm0RYFgqF-8C_YvFV5sOGixiacSZMfKR55lcUcD7IEdPkQ1zwFTtyOGd6_Vg37NvHs5vxc3N--enLuDtvJilAN6gAe4nOkZSDnYTTvbVaWdh2Q08ardBdK6RrtXADqu2gYWiFw9YNW2etVBv27rD3LsXfK-ViFp-n-goGims2stq7yrOi27DuMDqlmHMiZ-6SXzA9GBBmH4TZQzZ7yKYGYSSYfRDV9_bxxHq7kP3veiKv_gFC-IWG</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2540516304</pqid></control><display><type>article</type><title>Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non-Clear Cell Renal Cell Carcinoma</title><source>American Association for Cancer Research</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Armstrong, Andrew J ; Nixon, Andrew B ; Carmack, Andrea ; Yang, Qian ; Eisen, Tim ; Stadler, Walter M ; Jones, Robert J ; Garcia, Jorge A ; Vaishampayan, Ulka N ; Picus, Joel ; Hawkins, Robert E ; Hainsworth, John D ; Kollmannsberger, Christian K ; Logan, Theodore F ; Puzanov, Igor ; Pickering, Lisa M ; Ryan, Christopher W ; Protheroe, Andrew ; George, Daniel J ; Halabi, Susan</creator><creatorcontrib>Armstrong, Andrew J ; Nixon, Andrew B ; Carmack, Andrea ; Yang, Qian ; Eisen, Tim ; Stadler, Walter M ; Jones, Robert J ; Garcia, Jorge A ; Vaishampayan, Ulka N ; Picus, Joel ; Hawkins, Robert E ; Hainsworth, John D ; Kollmannsberger, Christian K ; Logan, Theodore F ; Puzanov, Igor ; Pickering, Lisa M ; Ryan, Christopher W ; Protheroe, Andrew ; George, Daniel J ; Halabi, Susan</creatorcontrib><identifier>ISSN: 1078-0432</identifier><identifier>EISSN: 1557-3265</identifier><identifier>DOI: 10.1158/1078-0432.CCR-21-1636</identifier><identifier>PMID: 34117029</identifier><language>eng</language><publisher>United States</publisher><ispartof>Clinical cancer research, 2021-06, Vol.27 (12), p.3503-3503</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2016-a31a72affe228dc0f67dd63d19587e6ad065402f460f8a39861840fa4f89fdd23</citedby><cites>FETCH-LOGICAL-c2016-a31a72affe228dc0f67dd63d19587e6ad065402f460f8a39861840fa4f89fdd23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,3356,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34117029$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Armstrong, Andrew J</creatorcontrib><creatorcontrib>Nixon, Andrew B</creatorcontrib><creatorcontrib>Carmack, Andrea</creatorcontrib><creatorcontrib>Yang, Qian</creatorcontrib><creatorcontrib>Eisen, Tim</creatorcontrib><creatorcontrib>Stadler, Walter M</creatorcontrib><creatorcontrib>Jones, Robert J</creatorcontrib><creatorcontrib>Garcia, Jorge A</creatorcontrib><creatorcontrib>Vaishampayan, Ulka N</creatorcontrib><creatorcontrib>Picus, Joel</creatorcontrib><creatorcontrib>Hawkins, Robert E</creatorcontrib><creatorcontrib>Hainsworth, John D</creatorcontrib><creatorcontrib>Kollmannsberger, Christian K</creatorcontrib><creatorcontrib>Logan, Theodore F</creatorcontrib><creatorcontrib>Puzanov, Igor</creatorcontrib><creatorcontrib>Pickering, Lisa M</creatorcontrib><creatorcontrib>Ryan, Christopher W</creatorcontrib><creatorcontrib>Protheroe, Andrew</creatorcontrib><creatorcontrib>George, Daniel J</creatorcontrib><creatorcontrib>Halabi, Susan</creatorcontrib><title>Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non-Clear Cell Renal Cell Carcinoma</title><title>Clinical cancer research</title><addtitle>Clin Cancer Res</addtitle><issn>1078-0432</issn><issn>1557-3265</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNo9kc1u1TAQhS1ERcuFRwB5ySbFYydOLrurqPxIVYvasram8RgMiV1sp6jvwEPjq9uymiPNnJnRdxh7A-IUoBveg-iHRrRKno7jVSOhAa30M3YCXdc3SuruedVPM8fsZc4_hYAWRPuCHasWoBdye8L-jjElmoqP4QPfhe8-_vKBMt_lHCePhSz_48sPfrmWKS61ga5Q4tdr8MUHf8tj4mf3lOLslzXzm0RYFgqF-8C_YvFV5sOGixiacSZMfKR55lcUcD7IEdPkQ1zwFTtyOGd6_Vg37NvHs5vxc3N--enLuDtvJilAN6gAe4nOkZSDnYTTvbVaWdh2Q08ardBdK6RrtXADqu2gYWiFw9YNW2etVBv27rD3LsXfK-ViFp-n-goGims2stq7yrOi27DuMDqlmHMiZ-6SXzA9GBBmH4TZQzZ7yKYGYSSYfRDV9_bxxHq7kP3veiKv_gFC-IWG</recordid><startdate>20210615</startdate><enddate>20210615</enddate><creator>Armstrong, Andrew J</creator><creator>Nixon, Andrew B</creator><creator>Carmack, Andrea</creator><creator>Yang, Qian</creator><creator>Eisen, Tim</creator><creator>Stadler, Walter M</creator><creator>Jones, Robert J</creator><creator>Garcia, Jorge A</creator><creator>Vaishampayan, Ulka N</creator><creator>Picus, Joel</creator><creator>Hawkins, Robert E</creator><creator>Hainsworth, John D</creator><creator>Kollmannsberger, Christian K</creator><creator>Logan, Theodore F</creator><creator>Puzanov, Igor</creator><creator>Pickering, Lisa M</creator><creator>Ryan, Christopher W</creator><creator>Protheroe, Andrew</creator><creator>George, Daniel J</creator><creator>Halabi, Susan</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20210615</creationdate><title>Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non-Clear Cell Renal Cell Carcinoma</title><author>Armstrong, Andrew J ; Nixon, Andrew B ; Carmack, Andrea ; Yang, Qian ; Eisen, Tim ; Stadler, Walter M ; Jones, Robert J ; Garcia, Jorge A ; Vaishampayan, Ulka N ; Picus, Joel ; Hawkins, Robert E ; Hainsworth, John D ; Kollmannsberger, Christian K ; Logan, Theodore F ; Puzanov, Igor ; Pickering, Lisa M ; Ryan, Christopher W ; Protheroe, Andrew ; George, Daniel J ; Halabi, Susan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2016-a31a72affe228dc0f67dd63d19587e6ad065402f460f8a39861840fa4f89fdd23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Armstrong, Andrew J</creatorcontrib><creatorcontrib>Nixon, Andrew B</creatorcontrib><creatorcontrib>Carmack, Andrea</creatorcontrib><creatorcontrib>Yang, Qian</creatorcontrib><creatorcontrib>Eisen, Tim</creatorcontrib><creatorcontrib>Stadler, Walter M</creatorcontrib><creatorcontrib>Jones, Robert J</creatorcontrib><creatorcontrib>Garcia, Jorge A</creatorcontrib><creatorcontrib>Vaishampayan, Ulka N</creatorcontrib><creatorcontrib>Picus, Joel</creatorcontrib><creatorcontrib>Hawkins, Robert E</creatorcontrib><creatorcontrib>Hainsworth, John D</creatorcontrib><creatorcontrib>Kollmannsberger, Christian K</creatorcontrib><creatorcontrib>Logan, Theodore F</creatorcontrib><creatorcontrib>Puzanov, Igor</creatorcontrib><creatorcontrib>Pickering, Lisa M</creatorcontrib><creatorcontrib>Ryan, Christopher W</creatorcontrib><creatorcontrib>Protheroe, Andrew</creatorcontrib><creatorcontrib>George, Daniel J</creatorcontrib><creatorcontrib>Halabi, Susan</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical cancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Armstrong, Andrew J</au><au>Nixon, Andrew B</au><au>Carmack, Andrea</au><au>Yang, Qian</au><au>Eisen, Tim</au><au>Stadler, Walter M</au><au>Jones, Robert J</au><au>Garcia, Jorge A</au><au>Vaishampayan, Ulka N</au><au>Picus, Joel</au><au>Hawkins, Robert E</au><au>Hainsworth, John D</au><au>Kollmannsberger, Christian K</au><au>Logan, Theodore F</au><au>Puzanov, Igor</au><au>Pickering, Lisa M</au><au>Ryan, Christopher W</au><au>Protheroe, Andrew</au><au>George, Daniel J</au><au>Halabi, Susan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non-Clear Cell Renal Cell Carcinoma</atitle><jtitle>Clinical cancer research</jtitle><addtitle>Clin Cancer Res</addtitle><date>2021-06-15</date><risdate>2021</risdate><volume>27</volume><issue>12</issue><spage>3503</spage><epage>3503</epage><pages>3503-3503</pages><issn>1078-0432</issn><eissn>1557-3265</eissn><cop>United States</cop><pmid>34117029</pmid><doi>10.1158/1078-0432.CCR-21-1636</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1078-0432 |
ispartof | Clinical cancer research, 2021-06, Vol.27 (12), p.3503-3503 |
issn | 1078-0432 1557-3265 |
language | eng |
recordid | cdi_proquest_miscellaneous_2540516304 |
source | American Association for Cancer Research; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
title | Correction: Angiokines Associated with Outcomes after Sunitinib or Everolimus Treatment in Patients with Non-Clear Cell Renal Cell Carcinoma |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T21%3A06%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Correction:%20Angiokines%20Associated%20with%20Outcomes%20after%20Sunitinib%20or%20Everolimus%20Treatment%20in%20Patients%20with%20Non-Clear%20Cell%20Renal%20Cell%20Carcinoma&rft.jtitle=Clinical%20cancer%20research&rft.au=Armstrong,%20Andrew%20J&rft.date=2021-06-15&rft.volume=27&rft.issue=12&rft.spage=3503&rft.epage=3503&rft.pages=3503-3503&rft.issn=1078-0432&rft.eissn=1557-3265&rft_id=info:doi/10.1158/1078-0432.CCR-21-1636&rft_dat=%3Cproquest_cross%3E2540516304%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2540516304&rft_id=info:pmid/34117029&rfr_iscdi=true |